Replies to post #17009 on Synaptogenix Inc (SNPX)

[DRK123]

Great overview, especially your rationale. Thank you

[Cyosol]

I don't think the FDA needs more safety data. That last patient checkup is probably just to make sure all placebo patients have declined far enough.

I'm sure nobody wants another set of results where the placebo group shows improvements over baseline because the trial was too short.